Company names starting with "O"

Patents whose numbers are in italics have been extended under 35 USC 156. Unless otherwise noted, all expiration dates include applicable Sec. 156 and pediatric (PED) extensions.

Octapharma Pharmazeutika Produktionsges.m.b.H.
Octagam (Injection) (Intravenous) Immune Globulin Intravenous (Human)
NDA Applicant: Octapharma Pharmazeutika Produktionsges.m.b.H.      BLA No.: 125062  Prod. No.: 001 Rx (5% 5.0G); 002 Rx (5% 1.0G); 003 Rx (5% 10G); 004 Rx (5% 2.5G); 005 Rx (5% 25G); 006 Rx (10% 20G); 007 Rx (10% 5G); 008 Rx (10% 2G); 009 Rx (10% 10G)
ExclusivityExpirationExclusivity Description
Exclusivity Type: Orphan Drug ExclusivityJul 15, 2028Orphan Designation: Treatment of dermatomyositis
Approved Labeled Indication: Treatment of dermatomyositis in adults
Exclusivity Protected Indication: Treatment of dermatomyositis in adults

Last edited: 19 August 2023
© 2001-2023 Bruce A. Pokras, All rights reserved worldwide